In vitro effects of SB202190 on Echinococcus granulosus

Korean Journal of Parasitology

Volumn 51, Issue 2, 2013, Pages 255-258

  Lv, Hailong ^a   Li, Siyuan ^a   Zhang, Jing ^a   Liang, Weihua ^a   Mu, Xiaoling ^a   Jiang, Yufeng ^a  

^a SHIHEZI UNIVERSITY   (China)

Author keywords

Echinococcus granulosus; Hydatid cyst; Protoscolex; SB202190

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE;

ANTHELMINTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DEATH; DOSE RESPONSE; DRUG EFFICACY; DRUG SCREENING; ECHINOCOCCUS GRANULOSUS; IN VITRO STUDY; NONHUMAN; PARASITE VIABILITY; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ECHINOCOCCUS GRANULOSUS; HYDATID CYST; PROTOSCOLEX; SB202190;

ANIMALS; ANTHELMINTICS; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHINOCOCCUS GRANULOSUS; IMIDAZOLES; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; PARASITIC SENSITIVITY TESTS; PYRIDINES; SURVIVAL ANALYSIS;

EID: 84877636397     PISSN: 00234001     EISSN: 17380006     Source Type: Journal    
DOI: 10.3347/kjp.2013.51.2.255     Document Type: Article

References (13)

1. McManus DP, Zhang W, Li J, Bartley PB. Echinococcosis. Lancet 2003; 362: 1295-1304.
2. Moro P, Schantz PM. Echinococcosis: a review. Int J Infect Dis 2009; 13: 125-133.
3. Tozar E, Topcu O, Karayalcin K, Akbay SI, Hengirmen S. The effects of cetrimide-chlorhexidine combination on the hepatopancreatico-biliary system. World J Surg 2005; 29: 754-758.
4. Topcu O, Sumer Z, Tuncer E, Aydin C, Koyuncu A. Efficacy of chlorhexidine gluconate during surgery for hydatid cyst. World J Surg 2009; 33: 1274-1280.
5. Moazeni M, Larki S. In vitro effectiveness of acidic and alkline solutions on scolices of hydatid cyst. Parasitol Res 2010; 106: 853-856.
6. Yong HY, Koh MS, Moon A. The p38 mapk inhibitors for the treatment of inflammatory diseases and cancer. Expert Opin Investig Drugs 2009; 18: 1893-1905.
7. Kammerer B, Scheible H, Albrecht W, Gleiter CH, Laufer S. Pharmacokinetics of ML3403 ({4-[5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenylethyl)-amine), a 4-pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor. Drug Metab Dispos 2007; 35: 875-883.
8. Gelmedin V, Caballero-Gamiz R, Brehm K. Characterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors. Biochem Pharmacol 2008; 76: 1068-1081.
9. Kapan M, Kapan S, Goksoy E, Perek S, Kol E. Postoperative recurrence in hepatic hydatid disease. J Gastrointest Surg 2006; 10: 734-739.
10. Albi A, Baudin F, Matmar M, Archambeau D, Ozier Y. Severe hypernatremia after hypertonic saline irrigation of hydatid cysts. Anesth Analg 2002; 95: 1806-1808.
11. Caglar R, Yuzbasioglu MF, Bulbuloglu E, Gul M, Ezberci F, Kale IT. In vitro effectiveness of different chemical agents on scolices of hydatid cyst. J Invest Surg 2008; 21: 71-75.
12. Paillas S, Boissière F, Bibeau F, Denouel A, Mollevi C, Causse A, Denis V, Vezzio-Vié N, Marzi L, Cortijo C, Ait-Arsa I, Askari N, Pourquier P, Martineau P, Del Rio M, Gongora C. Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma. Cancer Res 2011; 71: 1041-1049.
13. Brumlik MJ, Nkhoma S, Kious MJ, Thompson GR 3rd, Patterson TF, Siekierka JJ, Anderson TJ, Curiel TJ. Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication. Exp Parasitol 2011; 128: 170-175.